United Therapeutics Corporation Reports Second Quarter 2017 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P, Nasdaq drop on tech selloff as concerns about hawkish Fed, AI spending mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil prices steady as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
United Therapeutics (UTHR) Tops Q2 EPS by 76c, Sales Easily Beat
July 27, 2017 6:15 AM EDTUnited Therapeutics (NASDAQ: UTHR) reported Q2 EPS of $4.37, $0.76 better than the analyst estimate of $3.61. Revenue for the quarter came in at $444.6 million versus the consensus estimate of $391.53 million.
"Our second quarter total net revenues reached $445 million, our highest quarterly net revenue level ever,"... More
